CD8+ T cell exhaustion
CD8 + T cells are important for the protective immunity against intracellular pathogens and tumor. In the case of chronic infection or cancer, CD8 + T cells are exposed to persistent antigen and/or inflammatory signals. This excessive amount of signals often leads CD8 + T cells to gradual deteriorat...
Saved in:
Published in | Seminars in immunopathology Vol. 41; no. 3; pp. 327 - 337 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.05.2019
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
ISSN | 1863-2297 1863-2300 1863-2300 |
DOI | 10.1007/s00281-019-00744-5 |
Cover
Summary: | CD8
+
T cells are important for the protective immunity against intracellular pathogens and tumor. In the case of chronic infection or cancer, CD8
+
T cells are exposed to persistent antigen and/or inflammatory signals. This excessive amount of signals often leads CD8
+
T cells to gradual deterioration of T cell function, a state called “exhaustion.” Exhausted T cells are characterized by progressive loss of effector functions (cytokine production and killing function), expression of multiple inhibitory receptors (such as PD-1 and LAG3), dysregulated metabolism, poor memory recall response, and homeostatic proliferation. These altered functions are closely related with altered transcriptional program and epigenetic landscape that clearly distinguish exhausted T cells from normal effector and memory T cells. T cell exhaustion is often associated with inefficient control of persisting infections and cancers, but re-invigoration of exhausted T cells with inhibitory receptor blockade can promote improved immunity and disease outcome. Accumulating evidences support the therapeutic potential of targeting exhausted T cells. However, exhausted T cells comprise heterogenous cell population with distinct responsiveness to intervention. Understanding molecular mechanism of T cell exhaustion is essential to establish rational immunotherapeutic interventions. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Literature Review-3 ObjectType-Review-3 content type line 23 |
ISSN: | 1863-2297 1863-2300 1863-2300 |
DOI: | 10.1007/s00281-019-00744-5 |